arstechnica.com / .arstechnica-com / Page 4

OpenAI is seeking another $30 billion privately as its IPO plans slip.

The move will be part of a major overhaul of the ecosystem for website authentication.

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.

New sculpture depicts AI leaders escaping a sinking ship.

The deal, which is expected to close by year's end, is worth $8.2 billion.

FCC unlikely to stop Trump ads described as illegal taxpayer-funded propaganda.

So is SpaceX just being selfish or what?

Without a "full set of safeguards," agent accessed "system information and source code."

Lawmaker rejects Apple excuse for banning ICE-tracking apps as unconstitutional.

Between the cars and their companion apps, you're exposed to a lot of trackers.